Aranyak Rawal
Overview
Explore the profile of Aranyak Rawal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ammon J, Alexander J, Petit-Frere W, Alkhatib D, Rawal A, Newman G, et al.
Cardiooncology
. 2024 Nov;
10(1):78.
PMID: 39516896
Background: This study aimed to increase the index of suspicion for transthyretin amyloidosis (ATTR) among cardiologists leading to increased screening for amyloidosis. Methods: A retrospective algorithm was created to identify...
2.
Alkhatib D, Vega J, Pour-Ghaz I, Al-Taweel O, Khan S, DeCarr K, et al.
Mol Genet Metab
. 2023 Feb;
138(4):107538.
PMID: 36812723
Background: Anderson-Fabry disease (AFD) is a rare X-linked lysosomal storage disease due to a genetic variation in the α-galactosidase A (GLA) gene. As a result, the activity of the α-galactosidase...
3.
Almaddah N, Rawal A, Ardeshna D, Hesterberg K, Alsafwah S, Khouzam R, et al.
CJC Open
. 2020 Mar;
1(6):327-329.
PMID: 32159128
Cardiac involvement in myocarditis induced by Human Monocytic Ehrlichiosis infection is an incredibly uncommon complication with sparsely available literature. Also, this case highlights the importance of early recognition as a...
4.
Hesterberg K, Rawal A, Khan S, Rashid A, Jones D, Siddiqui T, et al.
Cardiovasc Revasc Med
. 2019 Nov;
21(6):792-796.
PMID: 31672535
Background: Aspirin (ASA) monotherapy is the current standard of care after coronary artery bypass grafting (CABG) to prevent saphenous vein graft (SVG) failure. Several small, randomized clinical trials (RCTs) have...
5.
Pour-Ghaz I, Manolukas T, Foray N, Raja J, Rawal A, Ibebuogu U, et al.
Ann Transl Med
. 2019 Oct;
7(17):421.
PMID: 31660320
One of the most important variables in assessing hemodynamic status in the intensive care unit (ICU) is the cardiac function and blood pressure. Invasive methods such as pulmonary artery catheter...
6.
Rawal A, Ardeshna D, Hesterberg K, Cave B, Ibebuogu U, Khouzam R
Ann Transl Med
. 2019 Oct;
7(17):419.
PMID: 31660318
Ultrasound assisted catheter-directed thrombolysis (UACT) is a relatively novel approach to treating acute pulmonary embolism (PE). It is an alternative to systemic thrombolysis with good success rates and low reported...
7.
Rawal A, Ardeshna D, Minhas S, Cave B, Ibeguogu U, Khouzam R
Ann Transl Med
. 2019 Oct;
7(17):411.
PMID: 31660310
Utilization of direct oral anticoagulants (DOAC) have steadily increased since their approval and are now recommended over warfarin for both stroke prevention in nonvalvular atrial fibrillation and treatment of venous...
8.
Cave B, Rawal A, Ardeshna D, Ibebuogu U, Sai-Sudhakar C, Khouzam R
Ann Transl Med
. 2019 Oct;
7(17):410.
PMID: 31660309
Newer P2Y12 inhibitors are prescribed in place of clopidogrel for patients with acute coronary syndrome (ACS) and are associated with significant bleeding risks. Currently, limited options exist for the management...
9.
Jagadish P, Kirolos I, Khare S, Rawal A, Lin V, Khouzam R
Ann Transl Med
. 2019 Oct;
7(17):407.
PMID: 31660306
The prevalence of atrial fibrillation (AF) is estimated to be 12 million by the year 2030. A subset of those patients fall into the category of post-operative atrial fibrillation (POAF)...
10.
Jones D, Minhas S, Fierro J, Ardeshna D, Rawal A, Cave B, et al.
Ann Transl Med
. 2019 Oct;
7(17):405.
PMID: 31660304
For patients with atrial fibrillation with concomitant acute coronary syndrome (ACS) requiring percutaneous coronary intervention (PCI), the increased risk of bleeding associated with the use triple therapy is well established....